U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Substance Class
Concept
Record UNII
F94OW58Y8V
Record Status non-approved
Record Version
  • Download
Name Type Language
AZITHROMYCIN
EP   ORANGE BOOK   USAN   USP   VANDF   WHO-DD  
USAN  
Official Name English
AZITHROMYCIN [ORANGE BOOK]
Preferred Name English
AZITHROMYCIN [VANDF]
Common Name English
AZITHROMYCIN [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 881322
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
NCI_THESAURUS C261
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
NDF-RT N0000007529
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
NDF-RT N0000175935
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
WHO-ATC S01AA26
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
WHO-ATC J01FA10
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
WHO-VATC QS01AA26
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
WHO-ATC J01RA07
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
NDF-RT N0000007529
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
WHO-ESSENTIAL MEDICINES LIST 6.2.2
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
NDF-RT N0000007529
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
LIVERTOX NBK548434
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
WHO-VATC QJ01FA10
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
Code System Code Type Description
USAN
Y-83
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
PRIMARY
MESH
D017963
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
PRIMARY
DRUG BANK
DB00207
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
PRIMARY
LACTMED
Azithromycin
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
PRIMARY
DRUG CENTRAL
276
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
PRIMARY
WIKIPEDIA
AZITHROMYCIN
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
PRIMARY
ChEMBL
CHEMBL529
Created by admin on Mon Mar 31 18:28:43 GMT 2025 , Edited by admin on Mon Mar 31 18:28:43 GMT 2025
PRIMARY
This is a sub-concept of substance:
Related Record Type Details
BINDER->LIGAND
BINDING
SUBSTANCE -> SUB_CONCEPT
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MAXIMUM TOLERATED DOSE TOXICITY STREPTOCOCCALl TONSILLITIS/PHARYNGITIS

Tmax PHARMACOKINETIC FORMULATION: IMMEDIATE RELEASE
PHARMACOKINETIC
MIC BIOLOGICAL SUSCEPTIBILITY: RESISTANT (R)

PATHOGEN: STREPTOCOCCI INCLUDING S. PNEUMONIAE

MIC BIOLOGICAL PATHOGEN: HAEMOPHILUS SP.

SUSCEPTIBILITY: SUSCEPTIBLE (S)

Volume of Distribution PHARMACOKINETIC INTRAVENOUS
PHARMACOKINETIC
ORAL BIOAVAILABILITY PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC FORMULATION: EXTENDED RELEASE

Biological Half-life PHARMACOKINETIC ROUTE OF ADMINISTRATION: ORAL, IV

POPULATION: INFANTS AND CHILDREN 4 MONTHS TO 15 YEARS

MIC BIOLOGICAL SUSCEPTIBILITY: SUSCEPTIBLE (S)

PATHOGEN: STREPTOCOCCI INCLUDING S. PNEUMONIAE

MIC BIOLOGICAL SUSCEPTIBILITY: SUSCEPTIBLE (S)

PATHOGEN: S. AUREUS

MIC BIOLOGICAL PATHOGEN: S. AUREUS

SUSCEPTIBILITY: INTERMEDIATE (I)

Biological Half-life PHARMACOKINETIC POPULATION: ADULTS

MIC BIOLOGICAL SUSCEPTIBILITY: RESISTANT (R)

PATHOGEN: S. AUREUS

Tmax PHARMACOKINETIC FORMULATION: EXTENDED RELEASE

MIC BIOLOGICAL SUSCEPTIBILITY: INTERMEDIATE (I)

PATHOGEN: STREPTOCOCCI INCLUDING S. PNEUMONIAE

This is a sub-concept of substance: